Pharmaceuticals & Biotechnology | Pharma & Biotech Resources

Big data is turning up everywhere. In this Process Perspectives podcast, Kaare Buch Petersen, Information Architect in Global IT at Christen Hansen, a Denmark-based supplier of bioscience products to food and health industries, talks about how his company has been using big data in the

The informatics landscape is changing quickly and innovation could be the key to increasing efficiency. Jeff Hurst, Senior Scientist at the Hershey's Company talks us through these changes and how the industry is moving away from robots towards more innovative methods

The pharma industry has a lot to learn from the food and beverage industry when it comes to contract manufacturing. To get to grips with this outsider's view, we spoke with Steve Hills, European Contract Manufacturing Director at Pepsico. Steve outlines where companies can go wrong

Where can companies go wrong in their relationship with a CMO and what have been the major changes in these relationships in recent years? We spoke with Jim Browne, former Director of External Supply at GlaxoSmithKline and currently Director at JTB Consultancy Ltd to find out the answers

Biobanks must face a broad range of demands during their operation and this must be taken into account in strategies and planning. Ahead of the Biobanking 2014 conference we spoke to Kathi Shea, former President of ISBER and Vice President BioServices, Precision for medicine. Kathi spoke

Most people understand that one of the greatest challenges with new technology or processes is getting them to integrate with existing systems. We spoke with James Brennan, Informatics Lead at the UK Biocentre about integrating their sample ordering system with an existing LIMS. We also

Creating a fit-for-purpose compound management and compound ordering system is a huge task, so often the best way to understand is to look at those who have done it before. We spoke to Claus Stie Kallesøe, Head of Research Informatics at Lundbeck about his experiences in this

"Clinical trial information is being routinely and legally witheld and this needs to end". This is the assertion of Dr. Ben Goldacre; a doctor, science writer, campaigner on scientific issues including clinical trial transparency and author of the book Bad Pharma. Pharma

In this interview Gawayne Mahboubian-Jones, Manager of Quality by Design for Philip Morris International, shares his views on international standards to support the application of Process Analytical Technology and key quality by design (QbD) trends in manufacturing. Mahboubian-Jones also

Safety-related drug attrition is obviously a huge problem in drug trials. How can companies work to reduce this? We spoke with Gareth Waldron Non-Clinical Safety Lead at Pfizer Neusentis about in vitro pharmacological profiling, how it could be implemented to reduce this attrition and

Desmond Hunt, Senior Scientific Liaison, United States Pharmacopoeia (USP), speaks to Andrea Charles from Pharma IQ, about the current standards and guidance for single-use systems and the expectations for the new chapter from the USP regarding single-use systems. Hunt also shares

In this Pharma IQ interview Tony Hitchcock, Technical Director at Cobra Biologics, speaks to Andrea Charles from Pharma IQ, about why single use systems are not implemented more commonly across the biomanufacturing industry and the challenges surrounding scale up. Hitchcock also shares

Smaller companies face differing challenges in Clinical Trial Supply, but they also have their own unique advantages. We spoke to Ricardo Lima, Head of Pharmaceutical Development at Bial Research & Development about Bial's experiences.He discussses comparator sourcing,

There have been some high profile cases of antibodies causing severe reactions, as well as posing a high risk to patients, these late stage failures are hugely costly. Is there a way to prevent or predict these immune reactions to biologics? We spoke to Harald Kropshofer Senior

In this exclusive interview Alain Pralong, VP New Product Introduction and Technical Life Cycle Management at GlaxoSmithKline Vaccines, speaks to Andrea Charles from Pharma IQ, about the challenges faced e valuating single-use systems for extractables and leachables and i